Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALSARTAN Cause International normalised ratio increased? 27 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of International normalised ratio increased have been filed in association with VALSARTAN (valsartan). This represents 0.1% of all adverse event reports for VALSARTAN.

27
Reports of International normalised ratio increased with VALSARTAN
0.1%
of all VALSARTAN reports
1
Deaths
25
Hospitalizations

How Dangerous Is International normalised ratio increased From VALSARTAN?

Of the 27 reports, 1 (3.7%) resulted in death, 25 (92.6%) required hospitalization, and 3 (11.1%) were considered life-threatening.

Is International normalised ratio increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does VALSARTAN Cause?

Drug ineffective (1,845) Blood pressure increased (1,682) Dizziness (1,527) Headache (1,361) Hypertension (1,341) Acute kidney injury (1,301) Dyspnoea (1,239) Fatigue (1,156) Malaise (1,139) Hypotension (1,032)

What Other Drugs Cause International normalised ratio increased?

WARFARIN (5,622) RIVAROXABAN (863) ACETAMINOPHEN (533) ASPIRIN (448) APIXABAN (317) CLOPIDOGREL BISULFATE (314) FLUINDIONE (286) AMIODARONE (277) FUROSEMIDE (277) DABIGATRAN ETEXILATE (223)

Which VALSARTAN Alternatives Have Lower International normalised ratio increased Risk?

VALSARTAN vs VALTREX VALSARTAN vs VAMOROLONE VALSARTAN vs VANCOMYCIN VALSARTAN vs VANDETANIB VALSARTAN vs VARDENAFIL

Related Pages

VALSARTAN Full Profile All International normalised ratio increased Reports All Drugs Causing International normalised ratio increased VALSARTAN Demographics